Home > Healthcare & Medical Devices > Biosensors Market

Biosensors Market Size By Type (Wearable, Non-wearable), By Technology (Electrochemical, Optical, Thermal, Piezoelectric), By Medical Application (Blood Glucose Testing, Cholesterol Testing, Blood Gas Analysis, Pregnancy Testing, Drug Discovery, Infectious Disease Testing), By End-use (Point of Care Testing, Home Healthcare Diagnostics, Research Laboratories), Industry Analysis Report, Regional Outlook, Covid-19 Impact Analysis, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028

  • Report ID: GMI747
  • Published Date: Apr 2022
  • Report Format: PDF

Industry Overview

Biosensors Market size exceeded USD 26 billion in 2021 and is set to register over 7.3% CAGR between 2022 and 2028.  Rapid advancement in the industry including emergence of nanotechnology in biosensors is one of leading factor driving market growth.
 

Biosensors Market

Get more details on this report - Request Free Sample PDF
 

Biosensors developed using nanotechnology are mainly composed of nanoparticles with diameters ranging between 1 to 100 nanometres. Nano-electromechanical systems have been built by combination of electrical system and nanomaterial-based devices. The mechanical as well as electrical properties of numerous nanomaterials have been studied for application in enhancing transduction mechanism along with biological signalling, that leads to conversion of one form of energy into another.
 

Nanorods, nanotubes, nanowires, nanoparticles, and thin films composed of crystalline solids are some examples of commonly used materials. These devices can be utilized in a range of applications, including amperometric glucose detection, quantum dots as fluorescent agent for detection of binding activity, and use of bio-conjugated nanomaterials for biomolecular detection. Thus, aforementioned factors will fuel the overall market statistics.
 

The COVID-19 virus outbreak has positively influenced the biosensors market growth. Sudden upsurge in number of patients has elevated the demand for biosensors in several countries. Adding to this, several industry players are continuously involved in development of innovative biosensors for detection of COVID-19 virus thereby, demand for diagnostics has surged exponentially and rose by several folds. Moreover, some research organizations are also focusing on innovating face masks and wearable devices including smart watches for early detection of the pathogen as well as wide range of product approvals for emergency use in COVID-19 treatment. These factors have augmented market demand during the pandemic situation.
 

A biosensor is an analytical device containing an immobilized biological material such as an antibody, hormone, enzyme, organelle, or nucleic acid. These biosensors can interact with an analyte and produce an electrical, physical, or chemical signal that can be measured. Biosensors are devices that combine a physicochemical component and a biological component to detect an analyte into electrical measurement using electric circuits.
 

Rising application of biosensors in medical field will foster market expansion

Strong focus on discovery and development of novel biosensing therapeutics to offer highly specific treatment to complex and severe diseases such as cardiovascular disease, diabetes will stimulate market growth potential. The increasing use of biosensors in drug discovery, biomedicine, maintaining food safety standards, and environmental monitoring will further drive the industry landscape.
 

Collaborations between government organisations and research institutes to develop advanced and novel biosensors will also drive the market growth. For instance, In February 2018, the University of Cincinnati received a contract worth USD 750,000 for the development of real-time sweat biosensors.
 

Moreover, development of novel biosensors that enhance wound healing process are currently in developmental stage. Hence, growing government and private funding for development of next-generation innovative biosensing devices for medical applications is expected to lead to market growth in the forthcoming years.
 

Growing preference for wearable biosensors in home-based treatment will augment biosensors industry statistics

Global Biosensors Market By Type

Get more details on this report - Request Free Sample PDF
 

Biosensors market based on type is classified into wearable and non-wearable. Wearable biosensors segment dominated the biosensors industry with more than 57% market share in 2021. Wearable biosensors aim to shift the paradigm from centralised hospital-based care to home-based personal care, lowering healthcare costs and diagnosis time. These devices are causing a surge of innovation in society today. Their convenience and improved effectiveness may provide a new level of insight into a patient's current health status. The real-time data deliverance enables better clinical judgments, that leads to improved health outcomes and more efficient health-care utilisation.
 

Moreover, several market players are also focusing on development of innovative biosensors for rapid disease detection such as for COVID-19 patients. These developments will support the segmental growth during the analysis period.
 

High adoption of advanced biosensors will impel the industry revenue growth

Biosensors market by technology is classified into electrochemical, optical, thermal, piezoelectric, and others. Electrochemical segment is anticipated to proceed at 7.4% CAGR over the analysis timeline. The advancements in wearable biosensors have resulted in highly sensitive electrochemical analysis, that enhances ECG, heart rate, and EEG measurement. Wearable electrochemical biosensors have been incorporated into textile materials and the epidermis to allow for real-time monitoring of numerous physiological variables in order to improve overall patient's physiological health. In the next years, such improvements will offer unprecedented growth opportunities to the segment in future.
 

Continuous advancements in biosensing devices coupled with growing diabetes population will fuel the segment’s growth potential

Biosensors market based on medical application is segmented into blood glucose testing, cholesterol testing, blood gas analysis, pregnancy testing, drug discovery, infectious disease testing, and others. Blood glucose testing segment surpassed USD 19 billion in 2021 owing to rising advancements in biosensor design for monitoring glucose and other body fluids except blood.
 

According to the study published by the American Chemical Society, novel biosensors for monitoring glucose levels in tears and sweat have been developed to provide real time data about the patient. Thus, development of such innovative devices monitoring blood glucose levels in real time especially for diabetic patient will stimulate the industry outlook in the forthcoming years.
 

Growing demand for homecare treatment with surge in patient population will fuel the segment growth potential

Biosensors market on the basis of end-use is segmented into point of care testing, home healthcare diagnostics, research laboratories, and others. Home healthcare diagnostics segment crossed USD 6.2 billion in 2021 owing to increasing advancements in the healthcare sector, a high rate of acceptance of new diagnostic procedures, and ease of use of home-based medical devices contributing to market growth. Demand for home diagnostics has increased considerably due to the new coronavirus outbreak. As a result, several healthcare companies are developing cost-effective, smaller, and easy-to-use biosensing devices that could be used by broader population at home. Home healthcare diagnostics with the help of biosensors will have a huge impact on the industry, thereby impelling segment demand.
 

Presence of key market players catering to large patient pool will stimulate the market demand in North America

North America Biosensors Market By Country

Get more details on this report - Request Free Sample PDF
 

North America biosensors market held majority of market share that accounted for more than 38% in 2021. The regional market growth is primarily due to growing prevalence of infectious diseases and rising application of point of care diagnostics for safe and early disease detection. Existence of a technologically advanced medical framework, sophisticated co-payment and insurance system enhances regional growth capabilities.
 

Moreover, increasing R&D investment by private and government organizations for development of novel biosensing therapeutics will further accelerate regional market size. Surging demand for rapid and portable tests, current expansion of molecular methods for development of rapid, inexpensive, and simple to use tests, increasing adoption of diagnostics for use in and away from the hospital setting will be a highly influential for industry expansion.
 

New product approvals and strategic alliances by established players will offer immense growth opportunities in the market

Some of notable players operating in the global biosensors industry include Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Bio-Rad Laboratories, Inc, Biosensors International Group, Ltd, Danaher Corporation, Dexcom, Inc, F. Hoffmann-La Roche Ltd, LifeScan Inc, Masimo, Nova Biomedical, Pinnacle Technology, QTL Biosystems, Siemens Healthineers AG, TE Connectivity Corporation, and Thermo-Fisher Scientific among others. These market players are adopting numerous growth strategies to strengthen their product portfolio and broaden market footprint to garner high profit levels as well as expand consumer portfolio of the company.
 

Some of the recent industry developments:

  • In April 2021, Abbott announced the distribution of its BinaxNOW COVID-19 Ag self-test to retailers across the U.S. This will benefit business growth of the company.
     
  • In August 2020, Ascensia Diabetes Care and Senseonics Holdings, Inc. entered in strategic partnership for commercialization of Senseonics’ Eversense CGM systems offering worldwide distribution rights to the company. This has resulted in geographic expansion of the company.
     

The biosensors market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028 for the following segments:

By Type

  • Wearable
  • Non-Wearable

By Technology

  • Electrochemical
  • Optical
  • Thermal
  • Piezoelectric
  • Others

By Medical Application

  • Blood Glucose Testing
  • Cholesterol Testing
  • Blood Gas Analysis
  • Pregnancy Testing
  • Drug Discovery
  • Infectious Disease Testing
  • Others

By End-use

  • Point of Care Testing
  • Home Healthcare Diagnostics
  • Research Laboratories
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Switzerland
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The global biosensors market revenue surpassed USD 26 billion in 2021 and is pegged to record a 7.3% CAGR through 2028 driven by the emergence of nanotechnology.

Wearable biosensors held over 57% of the biosensors industry share in 2021 and will rise with the increasing need for centralized hospital-based & home-based personal care, as well as lowered healthcare costs and diagnosis time.

The electrochemical biosensors industry is expected to record a 7.4% CAGR through 2028 with rising advancements in highly sensitive electrochemical analysis for enhancing the ECG, heart rate, and EEG measurement.

The biosensors market share from home healthcare diagnostics exceeded USD 6.2 billion in 2021 and will grow with rising advancements in the healthcare sector, and the higher acceptance of new diagnostic procedures.

North America held over 38% of the biosensors industry share in 2021 driven by the increasing prevalence of infectious diseases and the growing need for point of care diagnostics for safe and early disease detection.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2021
  • Companies covered: 15
  • Tables & Figures: 241
  • Countries covered: 16
  • Pages: 208

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount